Cargando…
Pharmacological Estrogen Administration Causes a FSH-Independent Osteo-Anabolic Effect Requiring ER Alpha in Osteoblasts
Postmenopausal osteoporosis is characterized by declining estrogen levels, and estrogen replacement therapy has been proven beneficial for preventing bone loss in affected women. While the physiological functions of estrogen in bone, primarily the inhibition of bone resorption, have been studied ext...
Autores principales: | Seitz, Sebastian, Keller, Johannes, Schilling, Arndt F., Jeschke, Anke, Marshall, Robert P., Stride, Brenda D., Wintermantel, Tim, Beil, Frank T., Amling, Michael, Schütz, Günther, Tuckermann, Jan, Schinke, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507728/ https://www.ncbi.nlm.nih.gov/pubmed/23209701 http://dx.doi.org/10.1371/journal.pone.0050301 |
Ejemplares similares
-
Osteoblast-specific inactivation of p53 results in locally increased bone formation
por: Liao, Nannan, et al.
Publicado: (2021) -
Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF–RANKL signaling
por: Bartelt, Alexander, et al.
Publicado: (2018) -
The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation
por: Schmidt, Katy, et al.
Publicado: (2005) -
Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway
por: Gao, Bo, et al.
Publicado: (2014) -
Correction: Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway
Publicado: (2014)